Lipopolysaccharide-binding molecules: Transporters, blockers and sensors

Cellular and Molecular Life Sciences

Volumn 61, Issue 14, 2004, Pages 1697-1713

  Chaby, R ^a  

^a CNRS   (France)

Author keywords

Antimicrobial; Binding; Defense; Endotoxin; Lipopolysaccharides

Indexed keywords

AMYLOID P COMPONENT; BACTERIAL PROTEIN; BIOLOGICAL FACTOR; CARRIER PROTEIN; CATHELICIDIN; COMPLEMENT; DEFENSIN; ENDOTOXIN; HEMOGLOBIN; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTOFERRIN; LIPID TRANSFER PROTEIN; LIPOPOLYSACCHARIDE; LYSOZYME; PEPTIDE DERIVATIVE; POLYMYXIN B; PROTEIN DERIVATIVE;

ARTHROPOD; BIOSENSOR; CORRELATION ANALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DROSOPHILA; EPITHELIUM CELL; ESCHERICHIA COLI; GRAM NEGATIVE ANAEROBIC BACTERIA; HEMOCONCENTRATION; HEMOLYMPH; HOST; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; LEGIONELLA PNEUMOPHILA; LEPTOSPIRA INTERROGANS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PAENIBACILLUS POLYMYXA; PORPHYROMONAS GINGIVALIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BLOCKING; REVIEW; RHIZOBIUM; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE;

ARTHROPODA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEPTOSPIRA; LEPTOSPIRA INTERROGANS; NEGIBACTERIA; PAENIBACILLUS POLYMYXA; POLYMYXA; PORPHYROMONAS; PORPHYROMONAS GINGIVALIS; RHIZOBIUM;

EID: 3843151565     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4020-4     Document Type: Review

References (169)

1. Imoto M., Kusumoto S., Shiba T., Rietschel E. T., Galanos C. and Lüderitz O. (1985) Chemical structure of Escherichia coli lipid A. Tetrahedron Lett. 26: 907-908
2. Parrillo J. E. (1993) Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477
3. Medvedev A. E., Kopydlowski K. M. and Vogel S. N. (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J. Immunol. 164: 5564-5574
4. Peterson A. A., Haug A. and McGroarty E. J. (1986) Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4. J. Bacteriol. 165: 116-122
5. Thomassen E., Gielen G., Schutz M., Schoehn G., Abrahams J. P., Miller S. et al. (2003) The structure of the receptor-binding domain of the bacteriophage T4 short tail fibre reveals a knitted trimeric metal-binding fold. J. Mol. Biol. 331: 361-373
6. Schroeder T. H., Lee M. M., Yacono P. W., Cannon C. L., Gerceker A. A., Golan D. E. et al. (2002) CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc. Natl. Acad. Sci. USA 99: 6907-6912
7. Beisel H. G., Kawabata S., Iwanaga S., Huber R. and Bode W. (1999) Tachylectin-2: crystal structure of a specific GlcNAc/GalNAc-binding lectin involved in the innate immunity host defense of the Japanese horseshoe crab Tachypleus tridentatus. EMBO J. 18: 2313-2322
8. Mey A., Leffler H., Hmama Z., Normier G. and Revillard J. P. (1996) The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J. Immunol. 156: 1572-1577
9. Stahl P. D. (1992) The mannose receptor and other macrophage lectins. Curr. Opin. Immunol. 4: 49-52
10. Zhang Y., Suankratay C., Zhang X. H., Lint T. F. and Gewurz H. (1999) Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. Immunopharmacology 42: 81-90
11. Hampton R. Y. and Raetz C. R. (1991) Macrophage catabolism of lipid A is regulated by endotoxin stimulation. J. Biol. Chem. 266: 19499-19509
12. Munford R. S. and Hall C. L. (1989) Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. J. Biol. Chem. 264: 15613-15619
13. Munford R. S., Sheppard P. O. and O'Hara P. J. (1995) Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid. Res. 36: 1653-1663
14. Hirschfeld M., Ma Y., Weis J. H., Vogel S. N. and Weis J. J. (2000) Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165: 618-622
15. Goodman G. W. and Sultzer B. M. (1979) Characterization of the chemical and physical properties of a novel B-lymphocyte activator, endotoxin protein. Infect. Immun. 24: 685-696
16. Ferguson A. D., Welte W., Hofmann E., Lindner B., Holst O., Coulton J. W. et al. (2000) A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins. Structure Fold Des. 8: 585-592
17. Vandeputte-Rutten L., Kramer R. A., Kroon J., Dekker N., Egmond M. R. and Gros P. (2001) Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site. EMBO J. 20: 5033-5039
18. Stumpe S., Schmid R., Stephens D. L., Georgiou G. and Bakker E. P. (1998) Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J. Bacteriol. 180: 4002-4006
19. Zhou Z., White K. A., Polissi A., Georgopoulos C. and Raetz C. R. (1998) Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J. Biol. Chem. 273: 12466-12475
20. Chang G. (2003) Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. J. Mol. Biol. 330: 419-430
21. Lei M. G. and Morrison D. C. (1993) Lipopolysaccharide interaction with S2 subunit of pertussis toxin. J. Biol. Chem. 268: 1488-1493
22. Daugelavicius R., Bakiene E. and Bamford D. H. (2000) Stages of Polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob. Agents Chemother. 44: 2969-2978
23. Vaara M. (1992) Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56: 395-411
24. Koch P. J., Frank J., Schuler J., Kahle C. and Bradaczek H. (1999) Thermodynamics and structural studies of the interaction of Polymyxin B with deep rough mutant lipopolysaccharides. J. Colloid Interface Sci. 213: 557-564
25. Pristovsek P. and Kidric J. (1999) Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J. Med. Chem. 42: 4604-4613
26. Helander I. M., Kilpelainen I. and Vaara M. (1994) Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study. Mol. Microbiol. 11: 481-487
27. De Lucca A. J., Jacks T. J. and Brogden K. A. (1995) Binding between lipopolysaccharide and cecropin A. Mol. Cell. Biochem. 151: 141-148
28. Bland J. M., De Lucca A. J., Jacks T. J. and Vigo C. B. (2001) All-D-cecropin B: synthesis, conformation, lipopolysaccharide binding and antibacterial activity. Mol. Cell. Biochem. 218: 105-111
29. Okemoto K., Nakajima Y., Fujioka T. and Natori S. (2002) Participation of two N-terminal residues in LPS-neutralizing activity of sarcotoxin IA. J. Biochem. (Tokyo) 131: 277-281
30. David S. A., Mathan V. I. and Balaram P. (1992) Interaction of melittin with endotoxic lipid A. Biochim. Biophys. Acta 1123: 269-274
31. Carlsson A., Nystrom T., de Cock H. and Bennich H. (1998) Attacin - an insect immune protein - binds LPS and triggers the specific inhibition of bacterial outer-membrane protein synthesis. Microbiology 144: 2179-2188
32. Gough M., Hancock R. E. and Kelly N. M. (1996) Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64: 4922-4927
33. Matsuzaki K., Sugishita K. and Miyajima K. (1999) Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of Gram-negative bacteria. FEBS Lett. 449: 221-224
34. Tan N. S., Ng M. L., Yau Y. H., Chong P. K., Ho B. and Ding J. L. (2000) Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides. FASEB J. 14: 1801-1813
35. Aketagawa J., Miyata T., Ohtsubo S., Nakamura T., Morita T., Hayashida H. et al. (1986) Primary structure of limulus anticoagulant anti- lipopolysaccharide factor. J. Biol. Chem. 261: 7357-7365
36. Hoess A., Watson S., Siber G. R. and Liddington R. (1993) Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J. 12: 3351-3356
37. Kloczewiak M., Black K. M., Loiselle P., Cavaillon J. M., Wainwright N. and Warren H. S. (1994) Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. J. Infect. Dis. 170: 1490-1497
38. Morrison D. C. and Cochrane C. G. (1974) Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J. Exp. Med. 140: 797-811
39. Park C. T., Creasey A. A. and Wright S. D. (1997) Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14. Blood 89: 4268-4274
40. Tollefson J. H., Ravnik S. and Albers J. J. (1988) Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602
41. Tall A. R. (1993) Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274
42. Vesy C. J., Kitchens R. L., Wolfbauer G., Albers J. J. and Munford R. S. (2000) Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68: 2410-2417
43. Hailman E., Albers J. J., Wolfbauer G., Tu A. Y. and Wright S. D. (1996) Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 271: 12172-12178
44. Grunfeld C., Marshall M., Shigenaga J. K., Moser A. H., Tobias P. and Feingold K. R. (1999) Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252
45. Maier R. V., Mathison J. C. and Ulevitch R. J. (1981) Interactions of bacterial lipopolysaccharides with tissue macrophages and plasma lipoproteins. Prog. Clin. Biol. Res. 62: 133-155
46. van Oosten M., van de Bilt E., van Berkel T. J. and Kuiper J. (1998) New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect. Immun. 66: 5107-5112
47. Day J. R., Albers J. J., Lofton-Day C. E., Gilbert T. L., Ching A. F., Grant F. J. et al. (1994) Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 269: 9388-9391
48. Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C. et al. (1990) Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431
49. Ramadori G., Meyer zum Buschenfelde K. H., Tobias P. S., Mathison J. C. and Ulevitch R. J. (1990) Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology 58: 89-94
50. Mathison J. C., Tobias P. S., Wolfson E. and Ulevitch R. J. (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J. Immunol. 149: 200-206
51. Dankesreiter S., Hoess A., Schneider-Mergener J., Wagner H. and Miethke T. (2000) Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J. Immunol. 164: 4804-4811
52. Gutsmann T., Müller M., Carroll S. F., MacKenzie R. C., Wiese A. and Seydel U. (2001) Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect. Immun. 69: 6942-6950
53. Müller M., Scheel O., Lindner B., Gutsmann T. and Seydel U. (2003) The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J. Endotoxin Res. 9: 181-186
54. Thomas C. J., Kapoor M., Sharma S., Bausinger H., Zyilan U., Lipsker D. et al. (2002) Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett. 531: 184-188
55. Han J., Mathison J. C., Ulevitch R. J. and Tobias P. S. (1994) Lipopolysaccharide (LPS) binding protein, truncated at Ile197, binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269: 8172-8175
56. Wurfel M. M., Hailman E. and Wright S. D. (1995) Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181: 1743-1754
57. Gegner J. A., Ulevitch R. J. and Tobias P. S. (1995) Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270: 5320-5325
58. Yu B., Hailman E. and Wright S. D. (1997) Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99: 315-324
59. Labeta M. O., Durieux J. J., Fernandez N., Herrmann R. and Ferrara P. (1993) Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur. J. Immunol. 23: 2144-2151
60. Viriyakosol S., Tobias P. S., Kitchens R. L. and Kirkland T. N. (2001) MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276: 38044-38051
61. Shapiro R. A., Cunningham M. D., Ratcliffe K., Seachord C., Blake J., Bajorath J. et al. (1997) Identification of CD14 residues involved in specific lipopolysaccharide recognition. Infect. Immun. 65: 293-297
62. Juan T. S., Hailman E., Kelley M. J., Busse L. A., Davy E., Empig C. J. et al. (1995) Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270: 5219-5224
63. Frey E. A., Miller D. S., Jahr T. G., Sundan A., Bazil V., Espevik T. et al. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176: 1665-1671
64. Grossman N. and Leive L. (1984) Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J. Immunol. 132: 376-385
65. Jiang G. Z., Sugiyama T., Kato Y., Koide N. and Yokochi T. (1995) Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect. Immun. 63: 2537-2540
66. Vukajlovich S. W. (1986) Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A. Infect. Immun. 53: 480-485
67. Cooper N. R. and Morrison D. C. (1978) Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J. Immunol. 120: 1862-1868
68. Zohair A., Chesne S., Wade R. H. and Colomb M. G. (1989) Interaction between complement subcomponent Clq and bacterial lipopolysaccharides. Biochem. J. 257: 865-873
69. Brade V. and Kreuzpaintner G. (1980) Interaction of lipopolysaccharides and of lipid A from Yersinia enterocolitica with purified guinea pig C3. Immunobiology 156: 441-453
70. Edwards J. L. and Apicella M. A. (2002) The role of lipooligosaccharide in Neisseria gonorrhoeae pathogenesis of cervical epithelia: lipid A serves as a C3 acceptor molecule. Cell. Microbiol. 4: 585-598
71. Liu D., Cai S., Gu X., Scafidi J., Wu X. and Davis A. E. 3rd (2003) Cl inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J. Immunol. 171: 2594-2601
72. Parker T. S., Levine D. M., Chang J. C., Laxer J., Coffin C. C. and Rubin A. L. (1995) Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63: 253-258
73. Brandenburg K., Jurgens G., Andra J., Lindner B., Koch M. H., Blume A. et al. (2002) Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins. Eur. J. Biochem. 269: 5972-5981
74. Cardin A. D. and Weintraub H. J. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21-32
75. Rensen P. C., Oosten M., Bilt E., Eck M., Kuiper J. and Berkel T. J. (1997) Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J. Clin. Invest. 99: 2438-2445
76. Read T. E., Harris H. W., Grunfeld C., Feingold K. R., Calhoun M. C., Kane J. P. et al. (1993) Chylomicrons enhance endotoxin excretion in bile. Infect. Immun. 61: 3496-3502
77. Gewurz H., Zhang X. H. and Lint T. F. (1995) Structure and function of the pentraxins. Curr. Opin. Immunol. 7: 54-64
78. Loveless R. W., Floyd-O'Sullivan G., Raynes J. G., Yuen C. T. and Feizi T. (1992) Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid. EMBO J. 11: 813-819
79. de Haas C. J., van der Zee R., Benaissa-Trouw B., van Kessel K. P., Verhoef J. and van Strijp J. A. (1999) Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. Infect. Immun. 67: 2790-2796
80. Roth R. I., Kaca W. and Levin J. (1994) Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Prog. Clin. Biol. Res. 388: 161-172
81. Kaca W., Roth R. I. and Levin J. (1994) Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J. Biol. Chem. 269: 25078-25084
82. Jurgens G., Muller M., Koch M. H. and Brandenburg K. (2001) Interaction of hemoglobin with enterobacterial lipopolysaccharide and lipid A. Physicochemical characterization and biological activity. Eur. J. Biochem. 268: 4233-4242
83. Liepke C., Baxmann S., Heine C., Breithaupt N., Standker L. and Forssmann W. G. (2003) Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides. J. Chromatogr. B. Analyt .Technol. Biomed. Life Sci. 791: 345-356
84. Levy O., Canny G., Serhan C. N. and Colgan S. P. (2003) Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia. Biochem. Soc. Trans. 31: 795-800
85. Little R. G., Keiner D. N., Lim E., Burke D. J. and Conlon P. J. (1994) Functional domains of recombinant bactericidal/ permeability increasing protein (rBPI23). J. Biol. Chem. 269: 1865-1872
86. van Berkel P. H., Geerts M. E., van Veen H. A., Mericskay M., de Boer H. A. and Nuijens J. H. (1997) N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328: 145-151
87. Britigan B. E., Lewis T. S., Waldschmidt M., McCormick M. L. and Krieg A. M. (2001) Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol. 167: 2921-2928
88. Masson P. L., Heremans J. F. and Schonne E. (1969) Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658
89. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C. et al. (1995) Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312: 839-845
90. Majerle A., Kidric J. and Jerala R. (2003) Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J. Antimicrob. Chemother. 51: 1159-1165
91. Pereira H. A. (1995) CAP37, a neutrophil-derived multifunctional inflammatory mediator. J. Leukoc. Biol. 57: 805-812
92. Iversen L. F., Kastrup J. S., Bjorn S. E., Rasmussen P. B., Wiberg F. C., Flodgaard H. J. et al. (1997) Structure of HBP, a multifunctional protein with a serine proteinase fold. Nat. Struct. Biol. 4: 265-268
93. Brackett D. J., Lerner M. R., Lacquement M. A., He R. and Pereira H. A. (1997) A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infect. Immun. 65: 2803-2811
94. Heinzelmann M., Mercer-Jones M. A., Flodgaard H. and Miller F. N. (1998) Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation. J. Immunol. 160: 5530-5536
95. Brandenburg K., Koch M. H., and Seydel U. (1998) Biophysical characterisation of lysozyme binding to LPS Re and lipid A. Eur. J. Biochem. 258: 686-695
96. Nagpal S., Kaur K. J., Jain D. and Salunke D. M. (2002) Plasticity in structure and interactions is critical for the action of indolicidin, an antibacterial peptide of innate immune origin. Protein Sci. 11: 2158-2167
97. Shamova O., Brogden K. A., Zhao C., Nguyen T., Kokryakov V. N. and Lehrer R. I. (1999) Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect. Immun. 67: 4106-4111
98. Wang Y., Griffiths W. J., Curstedt T. and Johansson J. (1999) Porcine pulmonary surfactant preparations contain the antibacterial peptide prophenin and a C-terminal 18-residue fragment thereof. FEBS Lett. 460: 257-262
99. Harwig S. S., Kokryakov V. N., Swiderek K. M., Aleshina G. M., Zhao C. and Lehrer R. I. (1995) Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes. FEBS Lett. 362: 65-69
100. Path M. A., Wu X., Hileman R. E., Linhardt R. J., Kashem M. A., Nelson R. M. et al. (1998) Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J. Biol. Chem. 273: 13563-13569
101. Ding A., Thieblemont N., Zhu J., Jin F., Zhang J. and Wright S. (1999) Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Infect. Immun. 67: 4485-4489
102. Murakami Y., Shizukuishi S., Tsunemitsu A., Nakashima K., Kato Y. and Aimoto S. (1991) Binding of a histidine-rich peptide to Porphyromonas gingivalis. FEMS Microbiol. Lett. 66: 253-256
103. Bosshart H. and Heinzelmann M. (2003) Endotoxin-neutralizing effects of histidine-rich peptides. FEBS Lett. 553: 135-140
104. Hieshima K., Ohtani H., Shibano M., Izawa D., Nakayama T., Kawasaki Y. et al. (2003) CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170: 1452-1461
105. Andersson M., Girard R. and Cazenave P. (1999) Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin. Infect. Immun. 67: 201-205
106. Pena S. V., Hanson D. A., Carr B. A., Goralski T. J., and Krensky A. M. (1997) Processing, subcellular localization and function of 519 (granufysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158: 2680-2688
107. Levy O., Ooi C. E., Elsbach P., Doerfler M. E., Lehrer R. I. and Weiss J. (1995) Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s and defensins. J. Immunol. 154: 5403-5410
108. Hill C. P., Yee J., Selsted M. E. and Eisenberg D. (1991) Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251: 1481-1485
109. Turner J., Cho Y., Dinh N. N., Waring A. J. and Lehrer R. I. (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents. Chemother. 42: 2206-2214
110. Tack B. F., Sawai M. V., Kearney W. R., Robertson A. D., Sherman M. A., Wang W. et al. (2002) SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269: 1181-1189
111. Gutsmann T., Fix M., Larrick J. W. and Wiese A. (2000) Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids. J. Membr. Biol. 176: 223-236
112. Kuan S. F., Rust K. and Crouch E. (1992) Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J. Clin. Invest. 90: 97-106
113. Van Iwaarden J. F., Pikaar J. C., Storm J., Brouwer E., Verhoef J., Oosting R. S. et al. (1994) Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem. J. 303: 407-411
114. Head J. F., Mealy T. R., McCormack F. X. and Seaton B. A. (2003) Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J. Biol. Chem. 278: 43254-43260
115. Augusto L., Le Blay K., Auger G., Blanot D., and Chaby R. (2001) Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L776-785
116. Andersson M., Curstedt T., Jornvall H. and Johansson J. (1995) An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 362: 328-332
117. Augusto L. A., Li J., Synguelakis M., Johansson J. and Chaby R. (2002) Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J. Biol. Chem. 277: 23484-23492
118. Augusto L. A., Synguelakis M., Johansson J., Pedron T., Girard R. and Chaby R. (2003) Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide. Infect. Immun. 71: 61-67
119. Beamer L. J., Carroll S. F. and Eisenberg D. (1998) The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7: 906-914
120. Ried C., Wahl C., Miethke T., Wellnhofer G., Landgraf C., Schneider-Mergener J. et al. (1996) High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. J. Biol. Chem. 271: 28120-28127
121. Taylor A. H., Heavner G., Nedelman M., Sherris D., Brunt E., Knight D. et al. (1995) Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270: 17934-17938
122. Frecer V., Ho B. and Ding J. L. (2000) Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. Eur. J. Biochem. 267: 837-852
123. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J. and Mathison J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433
124. Delude R. L., Savedra R. Jr, Zhao H., Thieringer R., Yamamoto S., Fenton M. J. et al. (1995) CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92: 9288-9292
125. Poltorak A., He X., Smirnova I., Liu M. Y., Van Huffel C., Du X. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088
126. Hirschfeld M., Weis J. J., Toshchakov V., Salkowski C. A., Cody M. J., Ward D. C. et al. (2001) Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69: 1477-1482
127. Werts C., Tapping R. I., Mathison J. C., Chuang T. H., Kravchenko V., Saint Girons I. et al. (2001) Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346-352
128. Girard R., Pedron T., Uematsu S., Balloy V., Chignard M., Akira S. et al. (2003) Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell Sci. 116: 293-302
129. da Silva Correia J., Soldau K., Christen U., Tobias P. S. and Ulevitch R. J. (2001) Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129-21135
130. Yang R. B., Mark M. R., Gray A., Huang A., Xie M. H., Zhang M. et al. (1998) Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284-288
131. Mullen G. E., Kennedy M. N., Visintin A., Mazzoni A., Leifer C. A., Davies D. R et al. (2003) The role of disulfide bonds in the assembly and function of MD-2. Proc. Natl. Acad. Sci. USA 100: 3919-3924
132. Inohara N. and Nunez G. (2002) ML - a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem. Sci. 27: 219-221
133. Mancek M., Pristovsek P. and Jerala R. (2002) Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein. Biochem. Biophys. Res. Commun. 292: 880-885
134. Visintin A., Latz E., Monks B. G., Espevik T. and Golenbock D. T. (2003) Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278: 48313-48320
135. Kawasaki K., Nogawa H. and Nishijima M. (2003) Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis. J. Immunol. 170: 413-420
136. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y. et al. (2003) Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198: 1035-1042
137. Werner T., Borge-Renberg K., Mellroth P., Steiner H. and Hultmark D. (2003) Functional diversity of the Drosophila PGRP-LC gene cluster in the response to lipopolysaccharide and peptidoglycan. J. Biol. Chem. 278: 26319-26322
138. Triantafilou K., Triantafilou M. and Dedrick R. L. (2001) A CD14-independent LPS receptor cluster. Nat. Immunol. 2: 338-345
139. Wright S. D., Levin S. M., Jong M. T., Chad Z. and Kabbash L. G. (1989) CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169: 175-183
140. Ingalls R. R., Arnaout M. A. and Golenbock D. T. (1997) Outside-in signaling by lipopolysaccharide through a tailless integrin. J. Immunol. 159: 433-438
141. El-Samalouti V. T., Schletter J., Brade H., Brade L., Kusumoto S., Rietschel E. T. et al. (1997) Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies. Eur. J. Biochem. 250: 418-424
142. Pfeiffer A., Bottcher A., Orso E., Kapinsky M., Nagy P., Bodnar A. et al. (2001) Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31: 3153-3164
143. Malhotra R., Taylor N. R. and Bird M. I. (1996) Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site. Biochem. J. 314: 297-303
144. Malhotra R. and Bird M. I. (1997) L-selectin: a novel receptor for lipopolysaccharide and its potential role in bacterial sepsis. Bioessays 19: 919-923
145. Malhotra R., Priest R., Foster M. R. and Bird M. I. (1998) P-selectin binds to bacterial lipopolysaccharide. Eur. J. Immunol. 28: 983-988
146. Miyake K., Ogata H., Nagai Y., Akashi S. and Kimoto M. (2000) Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J. Endotoxin Res. 6: 389-391
147. Hampton R. Y., Golenbock D. T., Penman M., Krieger M. and Raetz C. R. (1991) Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352: 342-344
148. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M. and Resnick D. (1993) Molecular flypaper, host defense and atherosclerosis. Structure, binding properties and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569-4572
149. Kutuzova G. D., Albrecht R. M., Erickson C. M. and Qureshi N. (2001) Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells. J. Immunol. 167: 482-489
150. Detmers P. A., Thieblemont N., Vasselon T., Pironkova R., Miller D. S. and Wright S. D. (1996) Potential role of membrane internalization and vesicle fusion in adhesion of neutrophils in response to lipopolysaccharide and TNF. J. Immunol. 157: 5589-5596
151. Hornef M. W., Frisan T., Vandewalle A., Normark S. and Richter-Dahlfors A. (2002) Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195: 559-570
152. Thieblemont N. and Wright S. D. (1999) Transport of bacterial lipopolysaccharide to the golgi apparatus. J. Exp. Med. 190: 523-534
153. Hu Y., Fisette P. L., Denlinger L. C., Guadarrama A. G., Sommer J. A., Proctor R. A. et al. (1998) Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J. Biol. Chem. 273: 27170-27175
154. Denlinger L. C., Fisette P. L., Sommer J. A., Watters J. J., Prabhu U., Dubyak G. R. et al. (2001) The nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167: 1871-1876
155. Amar S., Oyaisu K., Li L. and Van Dyke T. (2001) Moesin: a potential LPS receptor on human monocytes. J. Endotoxin Res. 7: 281-286
156. Ding A., Sanchez E., Tancinco M. and Nathan C. (1992) Interactions of bacterial lipopolysaccharide with microtubule proteins. J. Immunol. 148: 2853-2858
157. Qureshi N., Perera P. Y., Shen J., Zhang G., Lenschat A., Splitter G. et al. (2003) The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J. Immunol. 171: 1515-1525
158. Augusto L. A., Decottignies P., Synguelakis M., Nicaise M., Le Marechal P. and Chaby R. (2003) Histones: a novel class of lipopolysaccharide-binding molecules. Biochemistry 42: 3929-3938
159. Emlen W., Holers V. M., Arend W. P. and Kotzin B. (1992) Regulation of nuclear antigen expression on the cell surface of human monocytes. J. Immunol. 148: 3042-3048
160. Bolton S. J. and Perry V. H. (1997) Histone H1; a neuronal protein that binds bacterial lipopolysaccharide. J. Neurocytol. 26: 823-831
161. Kim H. S., Cho J. H., Park H. W., Yoon H., Kim M. S. and Kim S. C. (2002) Endotoxin-neutralizing antimicrobial proteins of the human placenta. J. Immunol. 168: 2356-2364
162. Kim H. S., Yoon H., Minn I., Park C. B., Lee W. T., Zasloff M. et al. (2000) Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I. J. Immunol. 165: 3268-3274
163. Park I. Y., Park C. B., Kim M. S. and Kim S. C. (1998) Parasin I, an
164. Lemaire I., Yang H., Cantin M. F. and Lemaire S. (1994) Upregulation of cytokine production in alveolar macrophages by histogranin, a novel endogenous pentadecapeptide. Immunol. Lett. 41: 37-42
165. Chang L., Loranger S. S., Mizzen C., Ernst S. G., Allis C. D. and Annunziato A. T. (1997) Histones in transit: cytosolic histone complexes and diacetylation of H4 during nucleosome assembly in human cells. Biochemistry 36: 469-480
166. Inohara N., Ogura Y., Chen F. F., Muto A. and Nunez G. (2001) Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551-2554
167. Girardin S. E., Boneca I. G., Carneiro L. A., Antignac A., Jehanno M., Viala J. et al. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587
168. Pugin J., Heumann I. D., Tomasz A., Kravchenko V. V., Akamatsu Y., Nishijima M. et al. (1994) CD14 is a pattern recognition receptor. Immunity 1: 509-516
169. Goh Y. Y., Ho B. and Ding J. L. (2002) A novel fluorescent protein-based biosensor for gram-negative bacteria. Appl. Environ. Microbiol. 68: 6343-6352